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Abstract: Evidence supports the presence of comorbid conditions, e.g., irritable bowel syndrome
(IBS), in individuals with fibromyalgia (FM). Physical therapy plays an essential role in the treatment
of FM; however, it is not currently known whether the IBS comorbidity is considered in the selection
criteria for clinical trials evaluating physiotherapy in FM. Thus, the aim of the review was to identify
whether the presence of IBS was considered in the selection criteria for study subjects for those
clinical trials that have been highly cited or published in the high-impact journals investigating the
effects of physical therapy in FM. A literature search in the Web of Science database for clinical trials
that were highly cited or published in high-impact journals, i.e., first second quartile (Q1) of any
category of the Journal Citation Report (JCR), investigating the effects of physical therapy in FM was
conducted. The methodological quality of the selected trials was assessed with the Physiotherapy
Evidence Database (PEDro) scale. Authors, affiliations, number of citations, objectives, sex/gender,
age, and eligibility criteria of each article were extracted and analyzed independently by two authors.
From a total of the 412 identified articles, 20 and 61 clinical trials were included according to the
citation criterion or JCR criterion, respectively. The PEDro score ranged from 2 to 8 (mean: 5.9, SD:
0.1). The comorbidity between FM and IBS was not considered within the eligibility criteria of the
participants in any of the clinical trials. The improvement of the eligibility criteria is required in
clinical trials on physical therapy that include FM patients to avoid selection bias.
Keywords: fibromyalgia; irritable bowel syndrome; clinical trials; physiotherapy; eligibility criteria
1. Introduction
According to the American College of Rheumatology (ACR), fibromyalgia (FM) is
a chronic condition associated with widespread pain, fatigue, sleep problems and ten-
derness [1]. With a worldwide prevalence of 2–3% [2], its prevalence in Spain is 2.4% [3].
Although the diagnostic criteria have evolved from the exclusive presence of generalized
pain and pain on palpation at specific locations [4] to the inclusion of questionnaires on pain
perception and distress [5], its prevalence has increased as diagnostic criteria evolved [6].
Nonetheless, this pain condition is under-, over-, or misdiagnosed [7]. Regarding the
distribution by sex, FM is more frequent in women than in men (female: male ratio 9:1) [8].
Although FM is considered a noninflammatory generalized musculoskeletal pain condition
associated with fatigue and sleep disturbances, many patients also exhibit cognitive dys-
function (e.g., brain fog), mood disorders, or intestinal comorbidities, e.g., irritable bowel
syndrome (IBS) [9].
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The etiology and pathophysiology of FM are not well understood [2]. Current theories
describe a potential disorder of nociceptive pain processing and central sensitization as
the main pathophysiological mechanism [10]. Current evidence shows that individuals
with FM usually exhibit several medical comorbidities, e.g., diabetes mellitus, IBS, or mood
disorders [11]. Clinicians routinely overlook somatic symptoms, however, if comorbidities
are taken into account and treated appropriately, the severity of the symptoms in patients
with FM would be reduced [12].
Specifically, IBS is present in 46.2% of people with FM [13], whereas FM occurs in 12.9%
to 31.6% of patients with IBS [14]. Both conditions share a wide variety of symptoms such
as fatigue, insomnia, anxiety or depression, as well as a predilection for the female gender.
As in FM, the pathophysiology of IBS is not understood. There is a hypothesis suggesting
a dysregulation of the brain−gut axis resulting in a state of generalized hyperalgesia
(also known as central sensitivity disorders) leading to increased excitability of central
nociceptive pathways and inhibition of descending pain modulation [15]. This hypothesis
could explain the comorbidity presentation between FM and IBS and also the presence of
common symptoms.
This similarity between both syndromes should create the need to more exhaustively
define the selection of participants with FM in clinical trials [12,13]. Treatment of FM is
clearly multifactorial, but it seems that physical therapy has shown to be beneficial for these
patients. Several meta-analyses support that physical therapy interventions are effective
for reducing symptoms and for improving health-related quality of life in individuals with
FM, exercise probably being the most effective [16–18]. The main target of physical therapy
interventions is the musculoskeletal system, the presence of a comorbid visceral disorder,
e.g., IBS, could lead to the necessity of different therapeutic strategies.
Meta-analyses represent the highest level of evidence supporting or refuting a ther-
apeutic intervention, but they are based on randomized clinical trials. The influence of
relationships between FM with psychological and somatic-visceral conditions could lead
to uncertainty regarding the etiology of symptoms and may influence those clinical out-
comes. If medical comorbidities are ignored in the selection criteria of clinical trials, this
may limit the potential benefits of physical therapy, which mainly targets musculoskeletal
symptomatology. In fact, it has already been identified that the comorbid relationship of
IBS with temporomandibular disorders [19,20] is underreported when designing clinical
trials evaluating the effectiveness of physical therapy [21]. It is, therefore, reasonable to
consider that the relationship of FM with IBS could also influence clinical outcomes. No
study has previously investigated this topic in clinical trials including individuals with FM.
The objective of this scoping review was to identify whether the presence of IBS has been
considered in the participating selection criteria of “relevant” clinical trials evaluating the
effects of physical therapy in individuals with FM.
2. Methods
This scoping review was conducted following the methodological framework sug-
gested by Arksey and O’Malley [22] consisting of: 1, identify the research question; 2,
identify relevant studies; 3, study selection; 4, data extraction; 5, compiling, summarizing,
and reporting results. Additionally, it also adheres to the adjusted items for systematic
reviews and meta-analysis extension for scoping reviews (Prisma-ScR) and it has been
registered in The Open Science Framework Registry (https://osf.io/ns35d (accessed on 20
December 2020)).
2.1. Research Question
The research question of the current scoping review was: has the presence of visceral
disorders, e.g., IBS, been considered within the selection criteria of “relevant” clinical trials
investigating physical therapy interventions in individuals with FM?
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2.2. Identifying Relevant Studies
The literature search was conducted in the Web of Science (WOS) database from the
inception of the database to 22 December 2020. The search was conducted by two different
assessors and was limited to high-quality clinical trials including humans. No language
restriction was applied. A combination of the following terms employing Boolean operators
was used for the search: “fibromyalgia” AND, “physical therapy” OR “physiotherapy” OR
“exercise” OR “manual therapy”.
2.3. Study Selection
In this review, the PCC (Population, Concept and Context) mnemonic rule was used
to define the inclusion criteria.
Population: Men or women diagnosed with FM according to 1900 ACR diagnostic
criteria [4], 2010 ACR diagnostic criteria [23] or modified 2010 ACR classification criteria [5].
Alternative diagnostic criteria for FM were also accepted if properly described in the paper.
Concept: Randomized clinical trials evaluating any type of physical therapy interven-
tion, alone or in combination with others, in individuals with FM.
Context: Articles that met one of the following criteria were considered “relevant”:
1, most cited clinical trials from the selection; or, 2, clinical trials published in high im-
pact journals, e.g., of the first quartile (Q1) of any category of the Journal Citation Re-
ports (JCR) evaluated in the year of publication of the study, according to WOS (JCR
criterion−impact factor).
The selected studies were identified independently by two investigators considering
the title and abstract. For potentially eligible articles, the full text of the article was read.
If both researchers disagreed on the inclusion/exclusion of any of the articles, a third
researcher decided whether to include/exclude it. All data were saved and managed
through Microsoft Office.
2.4. Data Extraction
From selected studies, the following information was extracted following a standard-
ized form: number of authors affiliated with a clinical institution (e.g., hospital, private
clinic, or health center), number of authors affiliated with a nonclinical institution (e.g., uni-
versity or research center), total number of citations in WOS, PEDro score, study objectives,
sample size, characteristics of participants (sex distribution, mean age), and inclusion and
exclusion criteria for participants selection.
2.5. Methodological Quality
The Physiotherapy Evidence Database (PEDro) scale score was used to determine the
methodological quality of clinical trials. This scale contains 11 items, which can be scored
as absent (0) or present (1), except for the first item that refers to the external validity of
the study. Each item is scored from 0 to 10 points. The PEDro scale is a valid, reliable
and widely used tool for rating the methodological quality of clinical trials [24]. Studies
were considered to be of high quality if they obtained at least 5 points on this scale. The
score for each article was extracted from the PEDro database, except for those that were not
evaluated by the database. In this case, they were evaluated by two researchers following
the guidelines established by the PEDro scale [25].
3. Results
3.1. Study Selection
The search identified a total of 412 articles. Of these, 316 were excluded because they
did not meet any of the criteria. Of the remaining 96, the full text was accessed, after which
15 articles were excluded. Finally, 20 trials according to the citation criteria and another 61
published in Q1 JCR journals were included. Eight of the selected articles met both criteria;
accordingly, a total of 73 different clinical trials were included (Figure 1).
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Figure 1. PRISMA extension for scoping reviews (PRISMA-ScR) flow diagram. WOS: Web of Science; RCT: randomized
clinical trial; JCR: Journal Citation Reports.
3.2. Study Characteristics
Data extracted from the most cited trials are shown in Table 1, data from trials pub-
lished in Q1 of any category of the JCR are summarized in Table 2, and those fulfilling both
criteria are described in Table 3. The total number of citations from those trials included
in Tables 1–3 was 3502 (mean citations 175.1, SD: 53.7 per trial). It should be noted that
three clinical trials were based on the same sample population [26–28]; therefore, the first
published one was considered since the inclusion/exclusion criteria are the same [27].
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Authors from non-clinical institutions were part of all trials except one [92], whereas
authors from clinical institutions were present in 45.1% of the studies (n = 32/73). The
total number of participants in the clinical trials were 6688 (279 men and 6409 women).
Sixty-one percent of the trials (n = 45/73) just recruited women, and the remaining studies
presented a higher number of women than men in their sample. One study failed to specify
the sex [51], and another did not detail either sex or mean age [78]. Another trial did not
specify the mean age [36], which ranged from 38 to 59 years for the trial.
3.3. Methodological Quality
According to the PEDro scale, the methodological quality scores ranged from 2 to
8 points (mean: 5.9, SD: 0.1) out of a maximum of 10 points. From the 20 articles included
by citation criteria (mean: 5.6, SD: 0.1), all were rated ≥5 points, except one with a score of
4 [35]. In addition, 53 out of 61 of those published in Q1 JCR journal achieved ≥5 points
(mean score: 6, SD: 0.14), while the remaining 8 trials received <5 points. There were
four clinical trials without evaluation in the PEDro database. According to researchers
evaluation, three obtained a good methodological quality [48,56,63].
3.4. Inclusion Criteria in Clinical Trials
After examining the inclusion criteria of all trials, none considered comorbidity from a
visceral origin. Only two trials included the absence of concomitant somatic disorders but
without any other specification [48,84]. Generally, the common criterion for most clinical
trials was “Patients diagnosed with fibromyalgia according to ACR criteria”. Three clinical
trials presented diagnostic criteria that differed from the ACR, such as the criteria proposed
by Yunus [91], Smythe [95], or both authors [40]. In addition, five studies did not specify
which criteria they used for diagnosis of FM [34,51,52,56,62].
3.5. Exclusion Criteria in Clinical Trials
The exclusion criteria were heterogeneous and included pregnancy [27,46,47,53,59–
61,63,71,74,82,83,86,88,98], neurological diseases [29,35,37,39,41,44,62,65,77,81,82,84,97],
rheumatic diseases [29,32,33,39,41–44,47,55,57–60,65,74,77,79,80,83,88,91,94,98], psycholog-
ical/psychiatric conditions [27,32,38,42,45,46,49,50,55,59–61,63,64,66,69,70,73–75,79–83,89,
91,94], intake medication [32,35,41,44,49,54,57,58,64,66,75,95], diabetes mellitus [32,43,44,
55,57,58,65,85], cancer [32,34,46,58,64,67,82,89], skin disorders [29,50–52,92], trauma [59–61,
65,83,92], hypertension [32,42–44,57,58,65,66,72], migraine [59–61,83], osteoarthritis [30,43,66,
85,91], peripheral nerve entrapment [59–61,83], obesity [29,39,74], substance abuse [64,73,77],
and hypotension [50,51,65]. It is important to mention that in 54.7% (n = 40/73) of clini-
cal trials, people with cardiac, pulmonary or kidney diseases were excluded since these
“visceral” conditions could limit the therapeutic intervention used in these trials (ex-
ercise). Further, seven clinical trials excluded subjects with some visceral pathologies,




The current scoping review has observed that the presence of IBS, a common medical
comorbidity, is not consistently considered for the selection of participants in highly cited or
published in high-impact journal clinical trials investigating the effects of physical therapy
in FM, which could lead to a selection bias.
All clinical trials included individuals with a diagnosis of FM according to ACR cri-
teria, except Buckelew et al. [91], McCain et al. [95] and Wigers et al. [40] that used other
criteria. In addition, five studies [34,51,52,56,62] failed to specify the criteria by which the
diagnosis of FM was made. The exclusion criteria were generally more heterogeneous,
including psychological/psychiatric diseases, neurological diseases, rheumatic diseases,
medication, or diabetes mellitus, among the most common. In general, the presence of
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visceral pathology was not summarized as an exclusion criterion. Four studies considered
the possible comorbid conditions that may worsen FM symptomatology without specify-
ing any particular visceral pathology [50,64,89,90]. In addition to IBS, it is important to
highlight that other pathologies of visceral origin are also highly comorbid in FMS, and,
again, they were not considered in the included trials. This should prompt us to consider
the current diagnosis of FM, since it is mainly based on the presence of pain symptoms,
considering these comorbidities into this complex spectrum could help to improve the
quality of life and management of these patients. Interestingly, albeit the high comorbidity
between IBS and FM [12,99], no clinical trial included in this scoping review commented
anything on this relationship.
4.2. Why IBS Can Be Relevant for FMS Clinical Outcomes?
Current hypotheses support that IBS ad FMS share common underlying mechanisms
leading to increased excitability of central nociceptive pathways [15]. In fact, the presence
of previous IBS has been found to be the strongest predictor for new-onset FM develop-
ment [100]. The presence of comorbid visceral conditions, e.g., IBS, in a musculoskeletal
pain condition such as FM, should be considered in clinical practice since visceral pain
enhances sensitization [101]. An exacerbation of the symptoms when two comorbid con-
ditions exist is labeled as functional somatic syndrome [102], a situation which should be
carefully explored and considered in the management of chronic pain conditions exhibiting
manifestations at different levels such as those occurring in individuals with FM. In such
a scenario, early recognition of comorbid syndromes of different etiology, but exhibiting
a common mechanism, may identify subgroups of patients with different etiologies and
different needs of treatment [103].
Comorbid visceral conditions should not be ignored when a physical therapy inter-
vention is tested, as potentially occurred in the identified trials in the current scoping
review. We do not know if considering comorbid visceral conditions in people with mus-
culoskeletal pain conditions participating in physical therapy clinical trials could lead
to potentially different clinical outcomes. This is relevant, considering that visceral pain
shares several features with musculoskeletal pain but clearly requires different therapeutic
strategies. For instance, the current understanding of the neurosciences is continuously
evolving for better adaptation of exercise programs in individuals with nociplastic pain,
a category where FM could be included [104]. It is possible that individuals with FM
and comorbid IBS need different exercise programs to those with other comorbidities or
without IBS. Future clinical trials should investigate the effects of multimodal therapeutic
approaches considering the presence of these visceral comorbidities, e.g., IBS, in patients
with a primary musculoskeletal complaint, e.g., FM.
4.3. Strengths and Limitations
Findings from the current scoping review should be considered according to its
strengths and limitations. Strengths include a comprehensive literature search, method-
ological data extraction, and the inclusion of highly cited and published clinical trials in
high-impact journals investigating physical therapy for FM. Among the limitations, first,
the search was conducted on a single database, the WOS, because it is the only database
presenting the index classification by JCR. Second, physical therapy interventions were
heterogeneous, ranging from manual therapy to exercise alone or combined with physical
agents. Third, 95% of the patients included in the clinical trials were female; nonetheless,
this is related to the fact that FM is more prevalent in females and also that a greater
frequency of comorbidity in pain syndromes is present in females [105].
5. Conclusions
This scoping review found that highly cited clinical trials or those published in high
impact journals investigating the effects of physical therapy interventions in individuals
with FM did not consider the presence of comorbid IBS in their eligibility criteria. In
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turn, other pathologies were sometimes considered, mostly linked to exercise, e.g., cardiac
or kidney diseases. Current results highlight that the presence of intestinal pathology is
underestimated when treating a musculoskeletal pain condition. Based on our results,
stricter inclusion and exclusion criteria would be required in clinical trials involving
patients with FM to avoid possible subject selection biases.
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